Peter Hunt

Aug 6, 2024 | drugscience.org.uk | David Nutt |Tadeusz Hawrot |Peter Hunt

AuthorsProf David J NuttImperial College London; Drug Science Tadeusz HawrotPAREAPeter HuntMind Medicine Australia Dr Anne Katrin SchlagImperial College London; Drug SciencePublishedAugust 6, 2024MDMA [now called midomafetamine by the FDA] is a substituted amphetamine first synthesized in 1912 by Merck that has been developed over the past 30 years by the Multidisciplinary Association for Psychedelic Studies (MAPS) as a novel treatment for post-traumatic stress disorder (PTSD).

Jun 3, 2024 | mdpi.com | Peter Hunt |Mohammad Noori |Scott J. Hazelwood |Naudereh Noori

All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.